ABLI Sweden: Stockholm

    Abliva AB

    Last Updated: Oct 20, 2021 9:11 a.m. CEDT Delayed quote

    kr 0.53

    0.01 0.96%
    Previous Close
    Advanced Charting
    Volume: 48.05K 65 Day Avg: 982.64K
    5% vs Avg
    0.52 Day Range 0.53
    0.48 52 Week Range 0.98

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABLI Overview


    5 Day
    • 0.96%
    1 Month
    • -9.95%
    3 Month
    • -23.91%
    • -31.37%
    1 Year
    • -42.31%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 1 Full Ratings

    Recent News

    No Headlines Available

    No Headlines Available

    Abliva AB

    Abliva AB engages in the research and development of pharmaceuticals that protect mitochondria from death post acute traumatic injury. Its projects include KL1333 AND NV354. The company was founded by Eskil Elmer on February 1, 2000 and is headquartered in Lund, Sweden.


    Name Chg % Market Cap
    Swedish Orphan Biovitrum AB -0.04% kr69.93B
    Orexo AB 0.05% kr1.21B
    Karo Pharma AB -0.87% kr12.45B
    Active Biotech AB -2.17% kr296.44M
    Competitor Data Provided ByCapital Cube Logo